Outcomes of the Transcatheter aortic valve implantation- registry (QATAVI-registry) –first report 24/7/2024
<h3>Background</h3><p dir="ltr">Transcatheter aortic valve implantation (TAVI) is a therapeutic modality for high-surgical-risk patients with severe aortic stenosis. This study describes the outcomes of TAVI performed in Qatar. </p><h3>Methods </h3><p...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , , , , , , , |
| منشور في: |
2025
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1864513552089350144 |
|---|---|
| author | Abdulrahman Alnabti (20667683) |
| author2 | Salem Abujalala (18877372) Mohammed Al-Hijji (4050934) Khaled Othman (20667686) Ihsan Rafie (8100533) Jassim Al Suwaidi (284932) Huseyin Yalcin (20667689) Ruba Sulaiman (17734065) Ahmed Seri (20626445) Tahir Hamid (16869921) |
| author2_role | author author author author author author author author author |
| author_facet | Abdulrahman Alnabti (20667683) Salem Abujalala (18877372) Mohammed Al-Hijji (4050934) Khaled Othman (20667686) Ihsan Rafie (8100533) Jassim Al Suwaidi (284932) Huseyin Yalcin (20667689) Ruba Sulaiman (17734065) Ahmed Seri (20626445) Tahir Hamid (16869921) |
| author_role | author |
| dc.creator.none.fl_str_mv | Abdulrahman Alnabti (20667683) Salem Abujalala (18877372) Mohammed Al-Hijji (4050934) Khaled Othman (20667686) Ihsan Rafie (8100533) Jassim Al Suwaidi (284932) Huseyin Yalcin (20667689) Ruba Sulaiman (17734065) Ahmed Seri (20626445) Tahir Hamid (16869921) |
| dc.date.none.fl_str_mv | 2025-01-31T09:00:00Z |
| dc.identifier.none.fl_str_mv | 10.1016/j.ijcard.2025.133029 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/journal_contribution/Outcomes_of_the_Transcatheter_aortic_valve_implantation-_registry_QATAVI-registry_first_report_24_7_2024/28342154 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Biomedical and clinical sciences Cardiovascular medicine and haematology Clinical sciences Health sciences Epidemiology TAVI TAVR Aortic stenosis MACE Registry Qatar |
| dc.title.none.fl_str_mv | Outcomes of the Transcatheter aortic valve implantation- registry (QATAVI-registry) –first report 24/7/2024 |
| dc.type.none.fl_str_mv | Text Journal contribution info:eu-repo/semantics/publishedVersion text contribution to journal |
| description | <h3>Background</h3><p dir="ltr">Transcatheter aortic valve implantation (TAVI) is a therapeutic modality for high-surgical-risk patients with severe aortic stenosis. This study describes the outcomes of TAVI performed in Qatar. </p><h3>Methods </h3><p dir="ltr">The Qatar TAVI registry (QATAVI) was established to report the outcomes of TAVI procedures performed at Hamad Medical Corporation- Heart Hospital between October 2012 and December 2023. Data were collected both prospectively and retrospectively. </p><h3>Results </h3><p dir="ltr">241 patients underwent TAVI, with a mean age of 73 ± 8 years. The device success rate was 98.8 %. In-hospital para-valvular leak (PVL) was as follows; mild 8.3 %, moderate 0.8 %, and severe 0.0 %. At 1-year, PVL was mild 2.9 %, moderate 0.4 %, and severe 0.0 %. At 2 years, 0.4 % had mild PVL, moderate 0.4 %, and severe 0.0 %. The incidence of stroke was 2.1 % during hospitalization, 2.1 % at 1 year, and 1.2 % at 2 years. For myocardial infarction, the in-hospital rate was 0.8 %, at 1 year 3.3 %, and 1.2 % at 2 years. 3.7 % developed heart failure during the hospital stay, 15.4 % at 1 year, and 4.6 % at 2 years. The 30-day mortality rate was 2.0 %, while a 1-year survival rate was 91 %. Among the 1-year mortality, 67 % died from non-cardiovascular causes. </p><h3>Conclusion </h3><p dir="ltr">The inaugural report of QATAVI demonstrates a success rate that matches international standards, favorable early and late valvular functions, and improved clinical outcomes related to major adverse cardiovascular events. Moreover, the survival rates observed in this cohort align with those reported in global registries, demonstrating the safety and effectiveness of the TAVI procedure in Qatar.</p><h2>Other Information</h2><p dir="ltr">Published in: International Journal of Cardiology<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.ijcard.2025.133029" target="_blank">https://dx.doi.org/10.1016/j.ijcard.2025.133029</a></p> |
| eu_rights_str_mv | openAccess |
| id | Manara2_e1fd9f1d6a216cd051a91ecd687438a1 |
| identifier_str_mv | 10.1016/j.ijcard.2025.133029 |
| network_acronym_str | Manara2 |
| network_name_str | Manara2 |
| oai_identifier_str | oai:figshare.com:article/28342154 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Outcomes of the Transcatheter aortic valve implantation- registry (QATAVI-registry) –first report 24/7/2024Abdulrahman Alnabti (20667683)Salem Abujalala (18877372)Mohammed Al-Hijji (4050934)Khaled Othman (20667686)Ihsan Rafie (8100533)Jassim Al Suwaidi (284932)Huseyin Yalcin (20667689)Ruba Sulaiman (17734065)Ahmed Seri (20626445)Tahir Hamid (16869921)Biomedical and clinical sciencesCardiovascular medicine and haematologyClinical sciencesHealth sciencesEpidemiologyTAVITAVRAortic stenosisMACERegistryQatar<h3>Background</h3><p dir="ltr">Transcatheter aortic valve implantation (TAVI) is a therapeutic modality for high-surgical-risk patients with severe aortic stenosis. This study describes the outcomes of TAVI performed in Qatar. </p><h3>Methods </h3><p dir="ltr">The Qatar TAVI registry (QATAVI) was established to report the outcomes of TAVI procedures performed at Hamad Medical Corporation- Heart Hospital between October 2012 and December 2023. Data were collected both prospectively and retrospectively. </p><h3>Results </h3><p dir="ltr">241 patients underwent TAVI, with a mean age of 73 ± 8 years. The device success rate was 98.8 %. In-hospital para-valvular leak (PVL) was as follows; mild 8.3 %, moderate 0.8 %, and severe 0.0 %. At 1-year, PVL was mild 2.9 %, moderate 0.4 %, and severe 0.0 %. At 2 years, 0.4 % had mild PVL, moderate 0.4 %, and severe 0.0 %. The incidence of stroke was 2.1 % during hospitalization, 2.1 % at 1 year, and 1.2 % at 2 years. For myocardial infarction, the in-hospital rate was 0.8 %, at 1 year 3.3 %, and 1.2 % at 2 years. 3.7 % developed heart failure during the hospital stay, 15.4 % at 1 year, and 4.6 % at 2 years. The 30-day mortality rate was 2.0 %, while a 1-year survival rate was 91 %. Among the 1-year mortality, 67 % died from non-cardiovascular causes. </p><h3>Conclusion </h3><p dir="ltr">The inaugural report of QATAVI demonstrates a success rate that matches international standards, favorable early and late valvular functions, and improved clinical outcomes related to major adverse cardiovascular events. Moreover, the survival rates observed in this cohort align with those reported in global registries, demonstrating the safety and effectiveness of the TAVI procedure in Qatar.</p><h2>Other Information</h2><p dir="ltr">Published in: International Journal of Cardiology<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.ijcard.2025.133029" target="_blank">https://dx.doi.org/10.1016/j.ijcard.2025.133029</a></p>2025-01-31T09:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1016/j.ijcard.2025.133029https://figshare.com/articles/journal_contribution/Outcomes_of_the_Transcatheter_aortic_valve_implantation-_registry_QATAVI-registry_first_report_24_7_2024/28342154CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/283421542025-01-31T09:00:00Z |
| spellingShingle | Outcomes of the Transcatheter aortic valve implantation- registry (QATAVI-registry) –first report 24/7/2024 Abdulrahman Alnabti (20667683) Biomedical and clinical sciences Cardiovascular medicine and haematology Clinical sciences Health sciences Epidemiology TAVI TAVR Aortic stenosis MACE Registry Qatar |
| status_str | publishedVersion |
| title | Outcomes of the Transcatheter aortic valve implantation- registry (QATAVI-registry) –first report 24/7/2024 |
| title_full | Outcomes of the Transcatheter aortic valve implantation- registry (QATAVI-registry) –first report 24/7/2024 |
| title_fullStr | Outcomes of the Transcatheter aortic valve implantation- registry (QATAVI-registry) –first report 24/7/2024 |
| title_full_unstemmed | Outcomes of the Transcatheter aortic valve implantation- registry (QATAVI-registry) –first report 24/7/2024 |
| title_short | Outcomes of the Transcatheter aortic valve implantation- registry (QATAVI-registry) –first report 24/7/2024 |
| title_sort | Outcomes of the Transcatheter aortic valve implantation- registry (QATAVI-registry) –first report 24/7/2024 |
| topic | Biomedical and clinical sciences Cardiovascular medicine and haematology Clinical sciences Health sciences Epidemiology TAVI TAVR Aortic stenosis MACE Registry Qatar |